Anti-Asthmatics And COPD Drugs Global Market Report 2021: COVID 19 Implications And Growth to 2030 Major players in the anti-asthmatics and chronic obstructive pulmonary disease (COPD) market are Novartis AG, Merck & Co, GlaxoSmithKline, Boehringer Ingelheim Gmbh and AstraZeneca. The global anti-asthmatics and copd drugs market is expected to decline from $75. May 03, 2021 06:43 ET | Source: ReportLinker ReportLinker Lyon, FRANCE New York, May 03, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Anti-Asthmatics And COPD Drugs Global Market Report 2021: COVID 19 Implications And Growth to 2030" - https://www.reportlinker.com/p06067848/?utm_source=GNW 38 billion in 2020 to $66.81 billion in 2021 at a compound annual growth rate (CAGR) of -11.4%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $86.44 billion in 2025 at a CAGR of 6.7%.